Related Experiment Videos
Pharmacological testing of anisocoria
Aileen A Antonio-Santos1, Ronel N Santo, Eric R Eggenberger
1Department of Neurology and Ophthalmology, Michigan State University, A217 Clinical Center, 138 Service Road, East Lansing, MI 48824, USA. Aileen.Antonio@ht.msu.edu
Expert Opinion on Pharmacotherapy
|October 4, 2005
Summary
Anisocoria, a difference in pupil size, can stem from various causes. This review highlights how specific eye drops help doctors diagnose the underlying reason for anisocoria, distinguishing benign from serious conditions.
Area of Science:
- Ophthalmology
- Clinical Neurology
Background:
- Anisocoria, a difference in pupil size, presents a diagnostic challenge due to its diverse etiologies.
- Causes range from benign physiological variations to critical neurological conditions.
Purpose of the Study:
- To discuss the clinical evaluation of anisocoria.
- To emphasize the role of pharmacological aids in differentiating causes of anisocoria.
Main Methods:
- Review of clinical evaluation strategies for anisocoria.
- Discussion of specific pharmacologic agents used in diagnosis.
Main Results:
- Pharmacological agents like cocaine, hydroxyamphetamine, pilocarpine, and apraclonidine are crucial for differential diagnosis.
- These agents help distinguish between physiological anisocoria, Horner syndrome, Adie pupil, pharmacological anisocoria, and third nerve palsy.
Conclusions:
- Accurate diagnosis of anisocoria is essential for appropriate patient management.
- Pharmacological testing is a key component of the clinical assessment of anisocoria.